Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US Study) from the Italian Sarcoma Group
Journal article published in 2020 by
Federica Grosso,
Lorenzo D’Ambrosio 
,
Massimo Zucchetti,
Toni Ibrahim,
Stefano Tamberi,
Cristina Matteo,
Eliana Rulli ,
Danila Comandini,
Emanuela Palmerini,
Giacomo Giulio Baldi,
Andrea DeCensi,
Marina Bergaglio,
Domenico Marra,
Emanuela Marchesi,
Giacomo Siri
and other authors.
,
Massimo Zucchetti,
Toni Ibrahim,
Stefano Tamberi,
Cristina Matteo,
Eliana Rulli ,
Danila Comandini,
Emanuela Palmerini,
Giacomo Giulio Baldi,
Andrea DeCensi,
Marina Bergaglio,
Domenico Marra,
Emanuela Marchesi,
Giacomo Siri
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 